Distalmotion, a pioneer in surgical robotics, has announced the achievement of a significant milestone: surpassing 1000 successful procedures with its surgical robot, Dexter.
Since its first commercial installation in 2022, Dexter has been treating patients across multiple countries and institutions. The robot is utilised in a wide range of procedures across general surgery, urology, and gynaecology, demonstrating its versatility, safety, and efficacy in treating patients.
"Our journey with Dexter has been nothing short of transformative," remarked Greg Roche, CEO of Distalmotion. "We are empowering robotic surgery with Dexter, removing barriers, and making best-in-class minimally invasive surgery more accessible to healthcare providers and patients alike. Surpassing 1000 procedures is a testament to the maturity and reliability of our platform, and we are immensely proud of this achievement."
